Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: June 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020388

« Back to Dashboard

NDA 020388 describes NAVELBINE, which is a drug marketed by Pierre Fabre and is included in one NDA. It is available from one supplier. Additional details are available on the NAVELBINE profile page.

The generic ingredient in NAVELBINE is vinorelbine tartrate. There are fifteen drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the vinorelbine tartrate profile page.

Summary for 020388

Tradename:	NAVELBINE
Applicant:	Pierre Fabre
Ingredient:	vinorelbine tartrate
Patents:	0
Formulation / Manufacturing:	see details

Pharmacology for NDA: 020388

Ingredient-type	Vinca Alkaloids

Suppliers and Packaging for NDA: 020388

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
NAVELBINE	vinorelbine tartrate	INJECTABLE;INJECTION	020388	NDA	Pierre Fabre Pharmaceuticals, Inc.	64370-532	N	64370-532-01
NAVELBINE	vinorelbine tartrate	INJECTABLE;INJECTION	020388	NDA	Pierre Fabre Pharmaceuticals, Inc.	64370-532	N	64370-532-02

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	INJECTABLE;INJECTION			Strength	EQ 10MG BASE/ML
Approval Date:	Dec 23, 1994	TE:	AP	RLD:	Yes

Expired US Patents for NDA 020388

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Pierre Fabre	NAVELBINE	vinorelbine tartrate	INJECTABLE;INJECTION	020388-001	Dec 23, 1994	➤ Sign Up	➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.